Inscor Inc. is Poised to Help Relieve Municipal Distress

With few other low-cost solutions to the problem available and only ever-rising costs looming, Inscor (OTCPK – IOGA) has an opportunity to effect real change in government financial management and generate significant revenue for itself in the coming years.

Read more...
 
Health Benefits Down to a “T”

Until the arrival of Plandai Biotechnology, Inc. (OTCQB – PLPL), even many wellness pundits were unaware that substantial increases in bioavailability and effectiveness of some products, like green tea extracts, were possible and would change the face of the industry.

Read more...
 
Big Pharma Could Take Notice of Nuvilex Inc.

As broad development of its proprietary live-cell encapsulation platform delivery system progresses, it is possible that “Big Pharma” takes notice of Nuvilex Inc. (OTCQB – NVLX).

Read more...
 
Nuvilex Inc. Reminiscent of Major Biotech Success Stories

On May 14, 2013, Goldman Small Cap Research published an Article on Nuvilex, Inc. (OTCQB – NVLX).

Read more...
 
A Rare Bargain

Today we are issuing an updated report on LIG Assets (LIGA). LIG Assets may be one of the most successful opportunistic investors and financiers of its size and its strategy could result in $3-4M in net profit this year. Such a return is 4x the current market cap, making LIG’s share price a rare bargain.

Read more...
 
Nuvilex Inc. Affiliate Readies for Future Clinical Trials

Nuvilex Inc. Affiliate Readies for Future Clinical Trials

Read more...
 
The Next Takeover Target
RealBiz Media Group, Inc. is on the cutting edge of a fast-growing, high value digital media platform for the real estate industry. Based on recent transactions we believe RBIZ could emerge as the next takeover candidate in the space. Our target is $4.00.
Read more...
 
Multiple Indications Equals Tens of Billions in Market Size for Nuvilex, Inc.

Nuvilex, Inc. (OTCQB – NVLX) is no one-trick pony. The Company’s live-cell encapsulation drug delivery platform has already demonstrated that it can significantly improve the efficacy and safety results in mid-stage clinical trial studies in patients in advanced stages of pancreatic cancer. But, as the development progresses, it is not inconceivable that the size of the market for platform reaches the tens of billions worldwide. 

Read more...
 
NVLX: Another State Makes It Official

Late last week, Governor Martin O’Malley made it official. Following a public bill-signing ceremony, the State of Maryland will now become the 19th state in the Union to approve a medical marijuana program.

Read more...
 
NVLX: Broader Medical Marijuana Research Forges Ahead

Broader Medical Marijuana Research Forges Ahead

Read more...
 
<< Start < Prev 31 32 33 34 35 36 37 38 39 Next > End >>

Page 32 of 39